Format

Send to

Choose Destination
Mamm Genome. 2019 Jun;30(5-6):143-150. doi: 10.1007/s00335-019-09804-5. Epub 2019 May 24.

New models for human disease from the International Mouse Phenotyping Consortium.

Author information

1
William Harvey Research Institute, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
2
Linus Pauling Institute and the Center for Genome Research and Biocomputing, Oregon State University, Corvallis, USA.
3
William Harvey Research Institute, School of Medicine and Dentistry, Queen Mary University of London, London, UK. d.smedley@qmul.ac.uk.

Abstract

The International Mouse Phenotyping Consortium (IMPC) continues to expand the catalogue of mammalian gene function by conducting genome and phenome-wide phenotyping on knockout mouse lines. The extensive and standardized phenotype screens allow the identification of new potential models for human disease through cross-species comparison by computing the similarity between the phenotypes observed in the mutant mice and the human phenotypes associated to their orthologous loci in Mendelian disease. Here, we present an update on the novel disease models available from the most recent data release (DR10.0), with 5861 mouse genes fully or partially phenotyped and a total number of 69,982 phenotype calls reported. With approximately one-third of human Mendelian genes with orthologous null mouse phenotypes described, the range of available models relevant for human diseases keeps increasing. Among the breadth of new data, we identify previously uncharacterized disease genes in the mouse and additional phenotypes for genes with existing mutant lines mimicking the associated disorder. The automated and unbiased discovery of relevant models for all types of rare diseases implemented by the IMPC constitutes a powerful tool for human genetics and precision medicine.

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center